IP Library › Assignment 071781/0425
Patent Assignment
Reel/Frame 071781/0425

Assignment of Assignor's Interest

Recorded: 2025-07-21 Pages: 5
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2024-06-27
Assignee
DEUTSCHES KREBSFORSCHUNGSZENTRUM
IM NEUENHEIMER FELD 280, HEIDELBERG, 69120, GERMANY
Covered Properties (8)
3-Oxo-2,6-Diphenyl-2,3-Dihydropyridazine-4-Carboxamides
Application: 16/303,539 →
Publication: US 2020/0237757
2-Heteroaryl-3-Oxo-2,3-Dihydropyridazine-4-Carboxamides for the Treatment of Cancer
Application: 16/485,049 →
Publication: US 2024/0294505
Sulphur Substituted 3-Oxo-2,3-Dihydropyridazine-4-Carboxamides
Application: 16/765,709 →
Publication: US 2020/0299269
2-Hetarylpyrimidine-4-Carboxamides as Aryl Hydrocarbon Receptor Anatgonists
Application: 16/765,778 →
Publication: US 2020/0289509
2-Phenylpyrimidine-4-Carboxamides as Ahr Inhibitors
Application: 16/765,780 →
Publication: US 2020/0283395
3-Oxo-6-Heteroaryl-2-Phenyl-2,3-Dihydropyridazine-4-Carboxamides
Application: 16/765,806 →
Publication: US 2020/0283402
[1,2,4]Triazolo[1,5-C]Quinazolin-5-Amines
Application: 17/634,930 →
Publication: US 2023/0113037
2-Heteroaryl-3-Oxo-2,3-Dihydropyridazine-4-Carboxamides for the Treatment of Cancer
Application: 17/819,602 →
Publication: US 2023/0121195
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 17, 2020
From: GUTCHER, ILONA; RÖHN, ULRIKE; SCHMEES, NORBERT; ZORN, LUDWIG
To: BAYER AKTIENGESELLSCHAFT; BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 051550/0188 →
Assignment of Assignor's Interest Jan 17, 2020
From: PLATTEN, MICHAEL
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 051550/0183 →
Assignment of Assignor's Interest Nov 2, 2020
From: LEFRANC, JULIEN; SCHMEES, NORBERT; RÖHN, ULRIKE; ZORN, LUDWIG
To: BAYER AKTIENGESELLSCHAFT; BAYER PHARMA AKTIENGESELLSCHAFT; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 054246/0641 →
Assignment of Assignor's Interest Nov 2, 2020
From: LEFRANC, JULIEN; SCHMEES, NORBERT; RÖHN, ULRIKE; ZORN, LUDWIG
To: BAYER AKTIENGESELLSCHAFT; BAYER PHARMA AKTIENGESELLSCHAFT; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 054246/0494 →
Assignment of Assignor's Interest Jun 9, 2021
From: ZORN, LUDWIG; RÖHN, ULRIKE; GUTCHER, ILONA; RÖSE, LARS
To: BAYER AKTIENGESELLSCHAFT; BAYER PHARMA AKTIENGESELLSCHAFT; DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 056491/0932 →
Assignment of Assignor's Interest Sep 9, 2021
From: SCHMEES, NORBERT; GUTCHER, ILONA; IRLBACHER, HORST; BADER, BENJAMIN
To: BAYER PHARMA AKTIENGESELLSCHAFT; DEUTSCHES KREBSFORSCHUNGSZENTRUM (DKFZ)
Reel/Frame 057432/0410 →
Assignment of Assignor's Interest Feb 3, 2022
From: PLATTEN, MICHAEL
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 058881/0966 →
Assignment of Assignor's Interest Feb 3, 2022
From: GUTCHER, ILONA; RÖHN, ULRIKE; ZORN, LUDWIG; RÖSE, LARS
To: BAYER AKTIENGESELLSCHAFT; BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 058953/0431 →
Assignment of Assignor's Interest Oct 28, 2022
From: PLATTEN, MICHAEL; BAUMANN, DANIEL
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 061579/0658 →
Assignment of Assignor's Interest Oct 28, 2022
From: BOTHE, ULRICH
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 061579/0618 →
Assignment of Assignor's Interest Oct 28, 2022
From: LEFRANC, JULIEN; SCHMEES, NORBERT; ZORN, LUDWIG; MEIER, ROBIN MICHAEL
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 061579/0587 →
Assignment of Assignor's Interest Nov 1, 2022
From: GUTCHER, ILONA; RÖHN, ULRIKE; SCHMEES, NORBERT; ZORN, LUDWIG
To: BAYER AKTIENGESELLSCHAFT; BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 061619/0070 →
Assignment of Assignor's Interest Nov 1, 2022
From: PLATTEN, MICHAEL
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 061619/0128 →
Assignment of Assignor's Interest Jul 21, 2025
From: BAYER AKTIENGESELLSCHAFT
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 071781/0417 →